PIPA5111520

Noggin Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5111520-Each-of-1 In Stock ₹ 48,905.50

PIPA5111520 - Each of 1

₹ 48,905.50

In Stock

Quantity

1

Base Price: ₹ 48,905.50

GST (18%): ₹ 8,802.99

Total Price: ₹ 57,708.49

Antigen

Noggin

Classification

Polyclonal

Formulation

PBS with 40% glycerol and 0.02% sodium azide; pH 7.2

Gene Accession No.

Q13253

Gene Symbols

NOG

Immunogen

Recombinant Protein corresonding to Human Noggin

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Applications

Immunohistochemistry

Conjugate

Unconjugated

Gene

NOG

Gene Alias

NOG; Noggin; Noggin precursor; noggin; LOW QUALITY PROTEIN: noggin; SYM1; symphalangism 1 (proximal); SYNS1; SYNS1A

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

9241

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIPA5111346

--

Img

Thermo Scientific

PIPA5111602

--

Img

Thermo Scientific

PIPA5111564

--

Img

Thermo Scientific

PIPA5111638

--

Img

Thermo Scientific

PIPA5111355

--

Img

Thermo Scientific

PIPA5111337

--

Img

Thermo Scientific

PIPA5111272

--

Img

Thermo Scientific

PIPA5111720

--

Description

  • Immunogen sequence: GQHYLHIRPA PSDNLPLVDL IEHPDPIFDP KEKDLNETLL RSLLGGHYDP GFMATS Noggin is involved in numerous developmental processes, such as neural tube fusion and joint formation
  • The morphogenesis of organs is initiated by a downgrowth from a layer of epithelial stem cells
  • This process is achieved through the receipt of signals from 1) a WNT protein (WNT3A) to stabilize beta-catenin; and 2) Noggin, which is a bone morphogenetic protein inhibitor
  • Noggin mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) have been identified, which have multiple joint fusion as their principal defect.